Business
CSL open to new manufacturing options after AstraZeneca production – Sydney Morning Herald
The biotech giant says it can hit the 50 million dose mark by December and is in talks with the government about how else it can help fight the pandemic.
Biotech giant CSL is in talks with the government about its longer-term role in Australias fight against coronavirus, as the company races to complete 50 million doses of the AstraZeneca vaccine by December.
The $123 billion blood plasma giant confirmed over the weekend that it was now producing more than 1 million doses of the vaccine per week, with more than 3.7 million doses released to the public by the end of April. There is a four-week quality control and approvals process that must be completed…
-
Noosa News23 hours agoMeet Chad Burgess, Pauline Hanson’s One Nation Party
-
General22 hours agoTyler Wright soaks up Bells Beach return as poor conditions at Rip Curl Pro sees men’s opening round called off
-
Noosa News24 hours agoWestern Queensland graziers begin grim stock count after catastrophic floods
-
General22 hours agoTruck driver charged with causing death by dangerous driving after highway crash